In cholangiocarcinoma tumor cells, the binding of STAT3 to the m6A writer gene results in the upregulation of m6A writers by cytokine IL-6, suggesting that m6A is a potential target in response to inflammation (163). The gene discussed is IL6; the disease is cholangiocarcinoma.